NovaBridge Biosciences
Net Cash Flow Breakdown
Total Cash from Operations: $675.1M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $0 | 0.0% |
| Other Investing | $0 | 0.0% |
| Working Capital | $81.4M | 12.1% |
| Other | $47.3M | 7.0% |
| Net Cash Flow | $546.4M | 80.9% |
Net Cash Flow Breakdown
Total Cash from Operations: $675.1M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $0 | 0.0% |
| Other Investing | $0 | 0.0% |
| Working Capital | $81.4M | 12.1% |
| Other | $47.3M | 7.0% |
| Net Cash Flow | $546.4M | 80.9% |